Janux Therapeutics (JANX) Shares Issued (2020 - 2026)

Janux Therapeutics (JANX) has 7 years of Shares Issued data on file, last reported at $10.4 million in Q1 2026.

• On a quarterly basis, Shares Issued rose 3.91% year-over-year to $10.4 million in Q1 2026; TTM through Mar 2026 was $10.4 million, a 3.91% increase from a year earlier, with the FY2025 full-year figure at $9.5 million, up 7.6% from the prior year.
• Shares Issued for Q1 2026 stood at $10.4 million, up from $9.5 million in the prior quarter.
• Over the last five years, Shares Issued for JANX reached as high as $10.4 million in Q1 2026 and fell as low as $5.0 million in Q1 2022.
• Historically, Shares Issued has averaged $8.4 million across 5 years, with a median of $8.9 million in 2023.
• Across the five-year window, Shares Issued soared 78.41% in 2023 and plunged 36.96% in 2024, its largest moves.
• Year by year, Shares Issued stood at $7.3 million in 2022, then rose by 8.76% to $8.0 million in 2023, then rose by 11.06% to $8.9 million in 2024, then climbed by 7.6% to $9.5 million in 2025, then grew by 8.78% to $10.4 million in 2026.
• Per Business Quant data, the three most recent Shares Issued figures were $10.4 million in Q1 2026, $9.5 million in Q4 2025, and $10.0 million in Q3 2025.